This compound is a pharmaceutical intermediate featuring a Boc-protected amino group and a methanesulfonate ester moiety. It is primarily used as a synthetic building block in organic chemistry and pharmaceutical manufacturing.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 917342-28-0
4-QuinazolineAcetic Acid 8-Fluoro-1,2,3,4-Tetrahydro-3-[2-Methoxy-5-(TrifluoroMethyl)Phenyl]-2-Oxo-Methyl ester
Pharmaceutical intermediate compound
Methyl (2E)-3-[3-fluoro-2-[[[[2-methoxy-5-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenyl]-2-propenoate
pharmaceutical intermediate
Tert-Butylazanium;(E,3R,5S)-7-(4-(4-fluorophenyl)-2-(methyl(methylsulfonyl)amino)-6-propan-2-ylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
Rosuvastatin calcium intermediate
2-Chloro-3-methyl-4-(trifluoromethyl)pyridine
Pharmaceutical intermediate for synthesis
2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclohexyl]ethyl methanesulfonate
VJAZODDQBCCEBS-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CCC(CC1)CCOS(=O)(=O)C
—